JP2004538477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004538477A5 JP2004538477A5 JP2003520382A JP2003520382A JP2004538477A5 JP 2004538477 A5 JP2004538477 A5 JP 2004538477A5 JP 2003520382 A JP2003520382 A JP 2003520382A JP 2003520382 A JP2003520382 A JP 2003520382A JP 2004538477 A5 JP2004538477 A5 JP 2004538477A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- level
- antibody
- time interval
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31322401P | 2001-08-17 | 2001-08-17 | |
| US31322101P | 2001-08-17 | 2001-08-17 | |
| US33498701P | 2001-10-23 | 2001-10-23 | |
| PCT/US2002/026321 WO2003015617A2 (en) | 2001-08-17 | 2002-08-16 | Assay method for alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009208372A Division JP5162553B2 (ja) | 2001-08-17 | 2009-09-09 | アルツハイマー病のアッセイ方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004538477A JP2004538477A (ja) | 2004-12-24 |
| JP2004538477A5 true JP2004538477A5 (enExample) | 2006-01-05 |
| JP4511830B2 JP4511830B2 (ja) | 2010-07-28 |
Family
ID=27405654
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003520382A Expired - Lifetime JP4511830B2 (ja) | 2001-08-17 | 2002-08-16 | アルツハイマー病のアッセイ方法 |
| JP2009208372A Expired - Lifetime JP5162553B2 (ja) | 2001-08-17 | 2009-09-09 | アルツハイマー病のアッセイ方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009208372A Expired - Lifetime JP5162553B2 (ja) | 2001-08-17 | 2009-09-09 | アルツハイマー病のアッセイ方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1416965B8 (enExample) |
| JP (2) | JP4511830B2 (enExample) |
| AT (1) | ATE381346T1 (enExample) |
| CA (1) | CA2457145C (enExample) |
| CY (1) | CY1107901T1 (enExample) |
| DE (1) | DE60224200T2 (enExample) |
| DK (1) | DK1416965T3 (enExample) |
| ES (1) | ES2295401T3 (enExample) |
| PT (1) | PT1416965E (enExample) |
| WO (1) | WO2003015617A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001062801A2 (en) | 2000-02-24 | 2001-08-30 | Washington University | Humanized antibodies that sequester amyloid beta peptide |
| ES2391905T3 (es) | 2001-08-17 | 2012-11-30 | Washington University | Método de ensayo para la enfermedad de alzheimer |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| ES2344645T3 (es) | 2003-02-10 | 2010-09-02 | Applied Molecular Evolution, Inc. | Moleculas de union al abeta. |
| EP1480041A1 (en) * | 2003-05-22 | 2004-11-24 | Innogenetics N.V. | Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease |
| GB0519398D0 (en) * | 2005-09-23 | 2005-11-02 | Antisoma Plc | Biological materials and uses thereof |
| KR20180058863A (ko) | 2005-11-30 | 2018-06-01 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
| PT1954718E (pt) | 2005-11-30 | 2014-12-16 | Abbvie Inc | Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| HRP20150237T1 (hr) | 2007-01-18 | 2015-04-10 | Eli Lilly And Company | Pegilirani fab protiv amiloida-beta |
| US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| JP5704533B2 (ja) * | 2009-02-13 | 2015-04-22 | 国立大学法人大阪大学 | アルツハイマー病の診断方法および診断薬 |
| DK2510359T3 (en) | 2009-12-11 | 2015-12-07 | Araclón Biotech S L | METHODS AND REAGENTS FOR IMPROVED DETECTION OF AMYLOID-BETA PEPTIDES |
| MX336196B (es) | 2010-04-15 | 2016-01-11 | Abbvie Inc | Proteinas de union a amiloide beta. |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| EP2511296A1 (en) | 2011-04-12 | 2012-10-17 | Araclón Biotech, S. L. | Antibody, kit and method for determination of amyloid peptides |
| ES2874704T3 (es) * | 2013-11-20 | 2021-11-05 | Univ Iowa Res Found | Procedimiento para monitorizar la eficacia de un tratamiento de la enfermedad de Alzheimer con una isoforma de ApoE |
| CN109187981A (zh) * | 2018-08-01 | 2019-01-11 | 万东山 | 一种快速检测β-淀粉样蛋白的量子点免疫层析试纸条与应用 |
| WO2020031116A1 (en) * | 2018-08-08 | 2020-02-13 | Seoul National University R&Db Foundation | Method of diagnosing and treating alzheimer disease using plasma tau level in conjunt ion with beta-amyloid level as diagnostic index |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1298436T3 (da) * | 1992-10-26 | 2010-10-25 | Elan Pharm Inc | Fremgangsmåde til identificering af inhibitorforbindelser for frisætning af beta-amyloidpeptid (BAP) |
| US7964192B1 (en) * | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US6730778B2 (en) * | 1997-12-19 | 2004-05-04 | Pharmacia And Upjohn Company | Human sel-10 polypeptides and polynucleotides that encode them |
| WO2001062801A2 (en) * | 2000-02-24 | 2001-08-30 | Washington University | Humanized antibodies that sequester amyloid beta peptide |
-
2002
- 2002-08-16 DE DE60224200T patent/DE60224200T2/de not_active Expired - Lifetime
- 2002-08-16 ES ES02766022T patent/ES2295401T3/es not_active Expired - Lifetime
- 2002-08-16 PT PT02766022T patent/PT1416965E/pt unknown
- 2002-08-16 AT AT02766022T patent/ATE381346T1/de active
- 2002-08-16 DK DK02766022T patent/DK1416965T3/da active
- 2002-08-16 CA CA2457145A patent/CA2457145C/en not_active Expired - Fee Related
- 2002-08-16 EP EP02766022A patent/EP1416965B8/en not_active Expired - Lifetime
- 2002-08-16 WO PCT/US2002/026321 patent/WO2003015617A2/en not_active Ceased
- 2002-08-16 JP JP2003520382A patent/JP4511830B2/ja not_active Expired - Lifetime
-
2008
- 2008-03-07 CY CY20081100267T patent/CY1107901T1/el unknown
-
2009
- 2009-09-09 JP JP2009208372A patent/JP5162553B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004538477A5 (enExample) | ||
| Jusko et al. | Plasma and tissue protein binding of drugs in pharmacokinetics | |
| JP2002533680A5 (enExample) | ||
| JP2006516116A5 (enExample) | ||
| Pickup et al. | Serum sialic acid concentration and coronary heart disease in NIDDM | |
| JP2004532817A5 (enExample) | ||
| KR101155294B1 (ko) | 면역특이적으로 ＢＬｙＳ에 결합하는 항체 | |
| US20220402979A1 (en) | Biomarkers and treatments of alzheimer's disease and mild cognitive impairment | |
| JP2009173684A (ja) | 腎臓結石疾患の予防のための希土類化合物の使用 | |
| Ruocco et al. | Life-threatening bullous dermatoses: Pemphigus vulgaris | |
| JP2004517824A5 (enExample) | ||
| AU2024201099A1 (en) | Treatment and prevention of Alzheimer's Disease (AD) | |
| CA2457145A1 (en) | Assay method for alzheimer's disease | |
| CN112312917A (zh) | 用于治疗幻觉及其相关病症的方法和组合物 | |
| JP2006505536A5 (enExample) | ||
| Massol et al. | Letter to the Editor regarding'Impact of Continuous Renal Replacement Therapy with Polyacrylonitrile-Derived Filter on Caspofungin Concentration: A Retrospective Study' | |
| Zhu et al. | Detection of IgE antibodies specific for 1-phenyl-2, 3-dimethyl-3-pyrazoline-5-one by RAST: a serological diagnostic method for sensitivity to pyrazoline drugs | |
| Sha et al. | In vivo electroporation of a new gene vaccine encoding ten repeats of Aβ3-10 prevents brain Aβ deposition and delays cognitive impairment in young Tg-APPswe/PSEN1dE9 mice | |
| DE60336063D1 (de) | Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren | |
| EP3137094A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| WO2002026193A3 (en) | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | |
| Huang et al. | Case report: atenolol overdose successfully treated with hemodialysis | |
| JP2004507712A5 (enExample) | ||
| JP5024695B2 (ja) | 腎疾患治療剤 | |
| WO2001059452A3 (en) | Method for diagnosing efficacy of xenotypic antibody therapy |